GABAA受体野生型和H129Y变体苯二氮卓类变抗结合位点的新型先导化合物筛选:硅基分子对接研究

{"title":"GABAA受体野生型和H129Y变体苯二氮卓类变抗结合位点的新型先导化合物筛选:硅基分子对接研究","authors":"S. Thota, Naresh Krishna Narasimha","doi":"10.1504/ijcbdd.2021.10042525","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13612,"journal":{"name":"Int. J. Comput. Biol. Drug Des.","volume":"117 1","pages":"377-409"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Screening for novel lead compounds targeting benzodiazepine allosteric binding site of wild-type and H129Y variant of GABAA receptor: an in-silico molecular docking study\",\"authors\":\"S. Thota, Naresh Krishna Narasimha\",\"doi\":\"10.1504/ijcbdd.2021.10042525\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13612,\"journal\":{\"name\":\"Int. J. Comput. Biol. Drug Des.\",\"volume\":\"117 1\",\"pages\":\"377-409\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Int. J. Comput. Biol. Drug Des.\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1504/ijcbdd.2021.10042525\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Int. J. Comput. Biol. Drug Des.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1504/ijcbdd.2021.10042525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}